Market Tracker

04/22 4:45pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

84.09
Data as of Apr 22
 +6.24 / +8.02%
Today’s Change
38.58
Today|||52-Week Range
119.42
+29.93%
Year-to-Date
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close77.85
Today’s open77.88
Day’s range76.99 - 84.25
Volume340,336
Average volume (3 months)305,993
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 04/22/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-84.67%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book5.72

Competitors

 Today’s
change
Today’s
% change
ITMNInterMune Inc+1.58+5.40%
XONIntrexon Corp+1.45+7.38%
AEGRAegerion Pharmaceuti...+1.23+2.80%
IMGNImmunoGen Inc+0.49+3.48%
Data as of 4:03pm ET, 04/22/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Financial Officer &
Senior Vice President
Carsten Boess
Corporate headquarters
Lexington, Massachusetts

Forecasts